Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Advanced Therapy Medicinal Products CDMO Market, by Indication
1.4.2 Global Advanced Therapy Medicinal Products CDMO Market, by Product
1.4.3 Global Advanced Therapy Medicinal Products CDMO Market, by Phase
1.4.4 Global Advanced Therapy Medicinal Products CDMO Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers : 2019, Jan – 2022, Aug) Leading Players
Chapter 4. Global Advanced Therapy Medicinal Products CDMO Market by Indication
4.1 Global Oncology Market by Region
4.2 Global Cardiology Market by Region
4.3 Global Central Nervous System & Musculoskeletal Market by Region
4.4 Global Infectious Disease Market by Region
4.5 Global Dermatology Market by Region
4.6 Global Endocrine, Metabolic, Genetic Market by Region
4.7 Global Immunology & Inflammation Market by Region
4.8 Global Ophthalmology Market by Region
4.9 Global Hematology Market by Region
4.1 Global Gastroenterology Market by Region
4.11 Global Others Market by Region
Chapter 5. Global Advanced Therapy Medicinal Products CDMO Market by Product
5.1 Global Gene Therapy Market by Region
5.2 Global Cell Therapy Market by Region
5.3 Global Tissue Engineered & Others Market by Region
Chapter 6. Global Advanced Therapy Medicinal Products CDMO Market by Phase
6.1 Global Phase I Market by Region
6.2 Global Phase II Market by Region
6.3 Global Phase III Market by Region
6.4 Global Phase IV Market by Region
Chapter 7. Global Advanced Therapy Medicinal Products CDMO Market by Region
7.1 North America Advanced Therapy Medicinal Products CDMO Market
7.1.1 North America Advanced Therapy Medicinal Products CDMO Market by Indication
7.1.1.1 North America Oncology Market by Country
7.1.1.2 North America Cardiology Market by Country
7.1.1.3 North America Central Nervous System & Musculoskeletal Market by Country
7.1.1.4 North America Infectious Disease Market by Country
7.1.1.5 North America Dermatology Market by Country
7.1.1.6 North America Endocrine, Metabolic, Genetic Market by Country
7.1.1.7 North America Immunology & Inflammation Market by Country
7.1.1.8 North America Ophthalmology Market by Country
7.1.1.9 North America Hematology Market by Country
7.1.1.10 North America Gastroenterology Market by Country
7.1.1.11 North America Others Market by Country
7.1.2 North America Advanced Therapy Medicinal Products CDMO Market by Product
7.1.2.1 North America Gene Therapy Market by Country
7.1.2.2 North America Cell Therapy Market by Country
7.1.2.3 North America Tissue Engineered & Others Market by Country
7.1.3 North America Advanced Therapy Medicinal Products CDMO Market by Phase
7.1.3.1 North America Phase I Market by Country
7.1.3.2 North America Phase II Market by Country
7.1.3.3 North America Phase III Market by Country
7.1.3.4 North America Phase IV Market by Country
7.1.4 North America Advanced Therapy Medicinal Products CDMO Market by Country
7.1.4.1 US Advanced Therapy Medicinal Products CDMO Market
7.1.4.1.1 US Advanced Therapy Medicinal Products CDMO Market by Indication
7.1.4.1.2 US Advanced Therapy Medicinal Products CDMO Market by Product
7.1.4.1.3 US Advanced Therapy Medicinal Products CDMO Market by Phase
7.1.4.2 Canada Advanced Therapy Medicinal Products CDMO Market
7.1.4.2.1 Canada Advanced Therapy Medicinal Products CDMO Market by Indication
7.1.4.2.2 Canada Advanced Therapy Medicinal Products CDMO Market by Product
7.1.4.2.3 Canada Advanced Therapy Medicinal Products CDMO Market by Phase
7.1.4.3 Mexico Advanced Therapy Medicinal Products CDMO Market
7.1.4.3.1 Mexico Advanced Therapy Medicinal Products CDMO Market by Indication
7.1.4.3.2 Mexico Advanced Therapy Medicinal Products CDMO Market by Product
7.1.4.3.3 Mexico Advanced Therapy Medicinal Products CDMO Market by Phase
7.1.4.4 Rest of North America Advanced Therapy Medicinal Products CDMO Market
7.1.4.4.1 Rest of North America Advanced Therapy Medicinal Products CDMO Market by Indication
7.1.4.4.2 Rest of North America Advanced Therapy Medicinal Products CDMO Market by Product
7.1.4.4.3 Rest of North America Advanced Therapy Medicinal Products CDMO Market by Phase
7.2 Europe Advanced Therapy Medicinal Products CDMO Market
7.2.1 Europe Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.1.1 Europe Oncology Market by Country
7.2.1.2 Europe Cardiology Market by Country
7.2.1.3 Europe Central Nervous System & Musculoskeletal Market by Country
7.2.1.4 Europe Infectious Disease Market by Country
7.2.1.5 Europe Dermatology Market by Country
7.2.1.6 Europe Endocrine, Metabolic, Genetic Market by Country
7.2.1.7 Europe Immunology & Inflammation Market by Country
7.2.1.8 Europe Ophthalmology Market by Country
7.2.1.9 Europe Hematology Market by Country
7.2.1.10 Europe Gastroenterology Market by Country
7.2.1.11 Europe Others Market by Country
7.2.2 Europe Advanced Therapy Medicinal Products CDMO Market by Product
7.2.2.1 Europe Gene Therapy Market by Country
7.2.2.2 Europe Cell Therapy Market by Country
7.2.2.3 Europe Tissue Engineered & Others Market by Country
7.2.3 Europe Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.3.1 Europe Phase I Market by Country
7.2.3.2 Europe Phase II Market by Country
7.2.3.3 Europe Phase III Market by Country
7.2.3.4 Europe Phase IV Market by Country
7.2.4 Europe Advanced Therapy Medicinal Products CDMO Market by Country
7.2.4.1 Germany Advanced Therapy Medicinal Products CDMO Market
7.2.4.1.1 Germany Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.1.2 Germany Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.1.3 Germany Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.4.2 UK Advanced Therapy Medicinal Products CDMO Market
7.2.4.2.1 UK Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.2.2 UK Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.2.3 UK Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.4.3 France Advanced Therapy Medicinal Products CDMO Market
7.2.4.3.1 France Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.3.2 France Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.3.3 France Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.4.4 Russia Advanced Therapy Medicinal Products CDMO Market
7.2.4.4.1 Russia Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.4.2 Russia Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.4.3 Russia Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.4.5 Spain Advanced Therapy Medicinal Products CDMO Market
7.2.4.5.1 Spain Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.5.2 Spain Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.5.3 Spain Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.4.6 Italy Advanced Therapy Medicinal Products CDMO Market
7.2.4.6.1 Italy Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.6.2 Italy Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.6.3 Italy Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.4.7 Rest of Europe Advanced Therapy Medicinal Products CDMO Market
7.2.4.7.1 Rest of Europe Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.7.2 Rest of Europe Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.7.3 Rest of Europe Advanced Therapy Medicinal Products CDMO Market by Phase
7.3 Asia Pacific Advanced Therapy Medicinal Products CDMO Market
7.3.1 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.1.1 Asia Pacific Oncology Market by Country
7.3.1.2 Asia Pacific Cardiology Market by Country
7.3.1.3 Asia Pacific Central Nervous System & Musculoskeletal Market by Country
7.3.1.4 Asia Pacific Infectious Disease Market by Country
7.3.1.5 Asia Pacific Dermatology Market by Country
7.3.1.6 Asia Pacific Endocrine, Metabolic, Genetic Market by Country
7.3.1.7 Asia Pacific Immunology & Inflammation Market by Country
7.3.1.8 Asia Pacific Ophthalmology Market by Country
7.3.1.9 Asia Pacific Hematology Market by Country
7.3.1.10 Asia Pacific Gastroenterology Market by Country
7.3.1.11 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Product
7.3.2.1 Asia Pacific Gene Therapy Market by Country
7.3.2.2 Asia Pacific Cell Therapy Market by Country
7.3.2.3 Asia Pacific Tissue Engineered & Others Market by Country
7.3.3 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.3.1 Asia Pacific Phase I Market by Country
7.3.3.2 Asia Pacific Phase II Market by Country
7.3.3.3 Asia Pacific Phase III Market by Country
7.3.3.4 Asia Pacific Phase IV Market by Country
7.3.4 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Country
7.3.4.1 China Advanced Therapy Medicinal Products CDMO Market
7.3.4.1.1 China Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.1.2 China Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.1.3 China Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.4.2 Japan Advanced Therapy Medicinal Products CDMO Market
7.3.4.2.1 Japan Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.2.2 Japan Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.2.3 Japan Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.4.3 India Advanced Therapy Medicinal Products CDMO Market
7.3.4.3.1 India Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.3.2 India Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.3.3 India Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.4.4 South Korea Advanced Therapy Medicinal Products CDMO Market
7.3.4.4.1 South Korea Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.4.2 South Korea Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.4.3 South Korea Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.4.5 Singapore Advanced Therapy Medicinal Products CDMO Market
7.3.4.5.1 Singapore Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.5.2 Singapore Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.5.3 Singapore Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.4.6 Malaysia Advanced Therapy Medicinal Products CDMO Market
7.3.4.6.1 Malaysia Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.6.2 Malaysia Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.6.3 Malaysia Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.4.7 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market
7.3.4.7.1 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.7.2 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.7.3 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Phase
7.4 LAMEA Advanced Therapy Medicinal Products CDMO Market
7.4.1 LAMEA Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.1.1 LAMEA Oncology Market by Country
7.4.1.2 LAMEA Cardiology Market by Country
7.4.1.3 LAMEA Central Nervous System & Musculoskeletal Market by Country
7.4.1.4 LAMEA Infectious Disease Market by Country
7.4.1.5 LAMEA Dermatology Market by Country
7.4.1.6 LAMEA Endocrine, Metabolic, Genetic Market by Country
7.4.1.7 LAMEA Immunology & Inflammation Market by Country
7.4.1.8 LAMEA Ophthalmology Market by Country
7.4.1.9 LAMEA Hematology Market by Country
7.4.1.10 LAMEA Gastroenterology Market by Country
7.4.1.11 LAMEA Others Market by Country
7.4.2 LAMEA Advanced Therapy Medicinal Products CDMO Market by Product
7.4.2.1 LAMEA Gene Therapy Market by Country
7.4.2.2 LAMEA Cell Therapy Market by Country
7.4.2.3 LAMEA Tissue Engineered & Others Market by Country
7.4.3 LAMEA Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.3.1 LAMEA Phase I Market by Country
7.4.3.2 LAMEA Phase II Market by Country
7.4.3.3 LAMEA Phase III Market by Country
7.4.3.4 LAMEA Phase IV Market by Country
7.4.4 LAMEA Advanced Therapy Medicinal Products CDMO Market by Country
7.4.4.1 Brazil Advanced Therapy Medicinal Products CDMO Market
7.4.4.1.1 Brazil Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.1.2 Brazil Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.1.3 Brazil Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.4.2 Argentina Advanced Therapy Medicinal Products CDMO Market
7.4.4.2.1 Argentina Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.2.2 Argentina Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.2.3 Argentina Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.4.3 UAE Advanced Therapy Medicinal Products CDMO Market
7.4.4.3.1 UAE Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.3.2 UAE Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.3.3 UAE Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.4.4 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market
7.4.4.4.1 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.4.2 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.4.3 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.4.5 South Africa Advanced Therapy Medicinal Products CDMO Market
7.4.4.5.1 South Africa Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.5.2 South Africa Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.5.3 South Africa Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.4.6 Nigeria Advanced Therapy Medicinal Products CDMO Market
7.4.4.6.1 Nigeria Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.6.2 Nigeria Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.6.3 Nigeria Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.4.7 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market
7.4.4.7.1 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.7.2 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.7.3 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market by Phase
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc. (Patheon, Inc.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 AGC Biologics, Inc. (AGC, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.2.5.3 Geographical Expansions:
8.3 Catalent, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Minaris Regenerative Medicine GmbH (Resonac Holdings Corporation)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 WuXi AppTec Co., Ltd. (WuXi Advanced Therapies)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Product Launches and Product Expansions:
8.5.4.2 Acquisition and Mergers:
8.5.4.3 Partnerships, Collaborations, and Agreements:
8.6 Lonza Group AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Geographical Expansions:
8.7 Celonic AG (JRS PHARMA GmbH & Co. KG)
8.7.1 Company Overview
8.8 Bio Elpida (Polyplus-transfection SA.)
8.8.1 Company Overview
8.9 Rentschler Biopharma SE
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Acquisition and Mergers:
Unique Offerings 